Axial length changes after one week of wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

General procedure for the synthesis of B. by Xueqin lu (22250795)

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

¹³C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

Synthesis process of Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

Microscopic view of <i>spirulina</i> spp. by Maha Rehman (17114332)

“…<div><p>The study investigated the effect of different temperatures on the growth, pigment production, oxidative stress markers, and antioxidant profile of <i>Spirulina</i> spp. The results showed that the maximum growth of <i>Spirulina</i> was observed at 20°C, while the chlorophyll a, chlorophyll b, and carotenoid contents decreased at higher temperatures. …”

Table of parameters. by Keith Fraser (1868587)

IC₅₀ values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)